Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study

Published:2024-07 Issue: Volume:186 Page:182-190
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

González-Martín Antonio,Chung Hyun Cheol,Saada-Bouzid Esma,Yanez Eduardo,Senellart Helene,Cassier Philippe A.,Basu Bristi,Corr Bradley R.,Girda Eugenia,Dutcus Corina,Okpara Chinyere E.,Ghori Razi,Jin Fan,Groisberg Roman,Lwin Zarnie

Publisher

Elsevier BV

Reference33 articles.

1. Ovarian cancer: sites of recurrence;Amate;Int. J. Gynecol. Cancer,2013

2. Epithelial ovarian cancer: evolution of management in the era of precision medicine;Lheureux;CA Cancer J. Clin.,2019

3. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Colombo;Ann. Oncol.,2019

4. Clinical research in ovarian cancer: consensus recommendations from the gynecologic Cancer InterGroup;Vergote;Lancet Oncol.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study;The Oncologist;2024-08-05

2. Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial;Med;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP